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Abstract:  Alphaherpesviruses  are  pathogens  that  invade  the  nervous  systems  of  their 
mammalian  hosts.  Directional  spread  of  infection  in  the  nervous  system  is  a  key 
component of the viral lifecycle and is critical for the onset of alphaherpesvirus-related 
diseases. Many alphaherpesvirus infections originate at peripheral sites, such as epithelial 
tissues, and then enter neurons of the peripheral nervous system (PNS), where lifelong 
latency  is  established.  Following  reactivation  from  latency  and  assembly  of  new  viral 
particles,  the  infection  typically  spreads  back  out  towards  the  periphery.  These  spread 
events result in the characteristic lesions (cold sores) commonly associated with herpes 
simplex  virus (HSV) and herpes zoster (shingles) associated  with  varicella zoster virus 
(VZV).  Occasionally,  the  infection  spreads  transsynaptically  from  the  PNS  into  higher 
order neurons of the central  nervous system (CNS). Spread of  infection  into the CNS, 
while rarer in natural hosts, often results in severe consequences, including death. In this 
review, we discuss the viral  and cellular  mechanisms that govern directional  spread of 
infection  in  the  nervous  system.  We  focus  on  the  molecular  events  that  mediate  long 
distance directional transport of viral particles in neurons during entry and egress. 
Keywords: alphaherpesvirus; herpes simplex virus; pseudorabies virus; axonal transport; 
directional spread; cytoskeleton 
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1. Introduction 
1.1. Alphaherpesvirinae  
Herpesviruses are characterized by a large double-stranded DNA genome, a complex enveloped 
virion  and  the  ability  to  establish  a  latent  phase  as  part  of  their  lifecycle  in  their  hosts  [1].  
The  mammalian  herpesviruses belong to the Herpesviridae  family and can be classified  into  three 
subfamilies, including the alphaherpesvirinae, betaherpesvirinae and gammaherpesvirinae. Members of 
each  subfamily  are  distinguished  based  on  their  genome  content,  the  cell  type  where  latency  is 
established in the host and the length of their productive replication cycle [1]. Alphaherpesviruses have 
the broadest host range [1]. These viruses are pantropic and neuroinvasive [2,3]. Once in the peripheral 
or  central  nervous  system,  infection  can  spread  within  chains  of  synaptically  connected  neurons.  
This review addresses the molecular mechanisms underlying neuronal invasion and directional spread 
of alphaherpesvirus infections. 
1.2. Model Alphaherpesviruses 
The human alphaherpesviruses include herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and 
varicella zoster virus (VZV). Furthermore, well-studied veterinary alphaherpesviruses include bovine 
herpesvirus type I (BHV-1), equine herpesvirus type I (EHV-1) and pseudorabies virus (PRV) [4]. 
Here, we focus primarily on HSV-1 and PRV, since both viruses have served as powerful models for 
understanding  the  molecular  details  of  viral  spread  and  pathogenesis,  both  in  vitro  and  in  vivo.  
In particular, several features make PRV an excellent model for studying alphaherpesvirus neuronal 
invasion  and  spread.  First,  PRV  shares  a  similar  genome  structure  to  VZV,  HSV-1  and  HSV-2,  
and  many  of  its  gene  products  are  functionally  homologous  to  those  encoded  by  these  human 
pathogens [5,6]. Second, PRV can be used to infect a wide variety of experimental animal models and 
cell types. While its natural host is the adult swine, PRV infects a remarkably broad host range of 
vertebrates,  with  the  exception  of  higher  order  primates,  such  as  humans  and  chimpanzees  [4].  
Third, PRV readily grows to high titers and is easy to manipulate in the laboratory. Purified viral DNA 
or  bacterial  artificial  chromosomes  carrying  the  entire  viral  genome  are  infectious  [7,8],  and 
sophisticated  molecular  biological  techniques  to  replace  and  manipulate  PRV  genes  are  well 
established. Fourth, working with PRV poses little to no risk for laboratory workers. Fifth, PRV serves 
as an excellent model for understanding the pathogenic consequences of alphaherpesvirus infections in 
animal models. Symptoms include severe pruritus and self-mutilation (known as the “mad itch”), as 
well as loss of motor coordination and ataxia. Infection of non-natural hosts with wild-type PRV is 
uniformly  lethal  [4].  Finally,  because  PRV  spreads  directionally  and  faithfully  within  chains  of 
synaptically  connected  neurons,  it  has  been  used  extensively  as  a  powerful  tool  for  studying  the 
architecture of mammalian neuronal circuits [9]. Viruses 2013, 5                               
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1.3. Neuronal Architecture, Directional Spread of Infection and Alphaherpesvirus Pathogenesis 
Spread  of  alphaherpesvirus  infection  occurs  between  synaptically  connected  neurons  over  long 
distances. Prior to entering the nervous system, alphaherpesviruses typically infect and replicate in 
somatic  cells  (such  as  epithelia)  (Figure  1).  Replication  in  these  cell  types  is  then  followed  by 
transmission of viral infection into neurons. To invade the nervous system of their hosts, viral particles 
enter nerve termini of the PNS and undergo retrograde transport towards the cell body, where they 
initiate a  lifelong  latent  infection  [10]. Following reactivation  from  latency, anterograde spread of 
infection  is  dependent  upon  axonal  sorting  and  transport  of  viral  particles  back  out  towards  the 
periphery (Figure 1) [11]. Occasionally, the infection can spread into the CNS, an event that is often 
associated  with  the  fatal  consequences  of  alphaherpesvirus  infection,  such  as  encephalitis  [12].  
Thus, targeted directional transport of viral particles in neurons, while poorly understood, is an integral 
part of the viral lifecycle. 
Figure  1.  Directional  spread  of  alphaherpesvirus  infection  in  the  mammalian  nervous 
system. In their hosts, alphaherpesvirus infections typically initiate at peripheral sites, such 
as mucosal epithelia. Next, viral particles enter at the termini of sensory neurons of the 
peripheral  nervous  system  (PNS).  These  particles  are  transported  long  distances  along 
axons in the retrograde direction towards cell bodies, where the genomes are deposited in 
the nucleus to establish lifelong latency. Following reactivation from latency, new viral 
particles  are  assembled  and  transported  towards  sites  of  egress.  Typically,  infections 
spreads in the anterograde direction back out towards the periphery. This is essential for 
spread between hosts. Infection may also spread trans-neuronally, from the PNS to the 
central  nervous  system  (CNS).  Spread  of  alphaherpesvirus  infection  into  the  CNS  is 
associated with lethal encephalitis. 
 
 
As a consequence of their ability to spread from the PNS to the central nervous system (CNS) or to 
infect  peripheral  tissues  of  non-neuronal  origin,  alphaherpesviruses  are  the  causative  agents  of  a 
variety  of  neurological  diseases  and  disorders  [12].  In  humans,  HSV-1  and  HSV-2  infections Viruses 2013, 5                               
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commonly result in recurrent epidermal lesions (cold sores). Occasionally, infection may lead to more 
serious  pathogenic  consequences,  such  as  meningoencephalitis,  blindness  and  neonatal  
infections  [13–15].  Additionally,  VZV  infection  causes  varicella  (chickenpox)  and  herpes  zoster 
(shingles) [16]. A variety of neurological complications are associated with VZV infections, including 
post-herpetic  neuralgia,  which  is  characterized  by  severe  and  constant  pain  in  the  affected  
dermatome [17]. Thus, the cellular and molecular underpinnings of alphaherpesvirus-inflicted neuronal 
damage,  while  poorly  characterized,  are  central  to  understanding  the  etiology  of  symptoms  and 
pathogenesis that occur as a result of infection. 
Neurons are highly polarized cells with extended axonal and dendritic processes [18]. The directed 
trafficking  of  intracellular  neuronal  cargoes,  such  as  ribonucleoprotein  complexes  (RNPs), 
mitochondria,  synaptic  vesicle  precursors  and  other  organelles,  to  specific  subcellular  domains  is 
required  to  maintain  both  cell  polarity  and  function  [19,20].  During  alphaherpesvirus  infection, 
bidirectional transport of viral particles in axons and dendrites is essential for spread both within and 
between hosts [9,11]. Very little is currently known about viral particle dynamics in dendrites. The 
vast majority of studies have focused on sorting and transport of herpesvirus particles in axons during 
entry and egress [11,20,21]. 
In vivo, directional spread is likely dependent upon the architecture and connectivity of the neuron 
cell  types  that  are typically  infected.  HSV-1,  HSV-2  and  VZV often  establish  latent  infections  in 
sensory  neurons  of  the  dorsal  root  and  trigeminal  ganglia  [12].  These  neurons  are  mostly 
pseudounipolar and, thus, have a bifurcated axon, such that one branch projects towards the periphery, 
while the other synapses with neurons of the CNS (Figure 1). Axonal sorting and anterograde transport 
of  newly  replicated  particles  is  thought  to  proceed  down  both  branches  of  these  axons  [11,22].  
This  presents  an  important  conundrum.  Following  reactivation  from  latency,  spread  of  infection 
towards the periphery is relatively common, whereas productive infection of the CNS is much rarer. 
Transsynaptic  movement of  viral particles  likely occurs routinely  from  infected PNS neurons  into 
higher order CNS neurons [23–25]. As evidence of this, HSV genomes are readily detectible in the 
CNS  of  infected  rodents  and  humans  [26–31].  Furthermore,  Chen  et  al.  demonstrated  that  latent  
HSV-1 and HSV-2 genomes could be reactivated from mouse brain stems, indicating that the CNS can 
be a latency site for HSV, with the potential to cause recurrent disease [23]. Similarly, latent PRV 
genomes have also been reported in brain tissue from adult swine, the virus’s natural host [32–36]. 
Infection  of  mice  with  a  virulent  strain  of  PRV  results  in  peripheral  disease  with  minimal  CNS 
invasion, while infection with an attenuated strain invades the CNS with minimal peripheral disease 
[37]. Thus, invasion of the PNS always follows infection of peripheral tissues, but spread to the CNS 
from the PNS depends on the extent of peripheral disease. Since both HSV-1 and PRV frequently gain 
access to the body of their natural hosts by infecting epithelial surfaces of the oronasal region, these 
viruses may also invade the CNS directly via the olfactory routes [38]. In brains of patients suffering 
from  herpes  simplex  encephalitis,  immunohistochemical  analysis  showed  an  enrichment  of  viral 
antigen mainly in the medial and inferior temporal lobes, hippocampus, amygdaloid nuclei, olfactory 
cortex, insula and cingulate gyrus [39]. This localization pattern would be consistent with entry of the 
virus  via  the  olfactory  pathway,  with  spread  along  the  base  of  the  brain  to  the  temporal  lobes. 
However, another possibility is that herpes simplex encephalitis may result from viral spread from the 
trigeminal ganglia to the temporal and frontal cortex, which would be consistent with the known site of Viruses 2013, 5                               
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HSV-1 latency. Further work is needed to understand the molecular factors that determine the route of 
alphaherpesvirus neuroinvasion. 
An important question is what are the viral or host factors that modulate or restrict the extent of 
viral neuroinvasion and replication in the CNS? An increasing amount of evidence suggests that the 
immune system plays a key role in this process by modulating reactivation from latency and viral gene 
expression. The innate response likely serves as the first line of defense. Toll-like receptors (TLRs) 
recognize  pathogen-associated  molecular  patterns  (PAMPs),  such  as  those  expressed  by  HSV-1. 
Activation of TLRs in neurons and glial cells leads to the production of cytokines that generate an 
antiviral response  by recruiting  macrophages or inducing proteins that degrade mRNA and  inhibit 
translation.  Similarly,  TLR-dependent  pathways  are  required  for  limiting  HSV-1  replication  in 
humans.  Casrouge  et  al.  previously  reported  that  autosomal  recessive  mutations  in  UNC-93B,  a 
transmembrane  protein  located  within  the  ER,  render  children  more  susceptible  to  herpes  simplex 
encephalitis  by  disrupting  the  interferon  (IFN)  response  pathway  [40].  UNC-93B  functions  by 
delivering TLR3, TLR7 and TLR9 from the ER to the endosome, the site at which they recognize 
PAMPs and initiate signaling cascades [41,42]. Recently, UNC-93B null patient-derived fibroblasts 
were  differentiated  into  induced  pluripotent  stem  cells  (iPSCs)  and  then  into  CNS-resident  cells, 
including  neural  stem  cells  (NSCs),  neurons,  astrocytes  and  oligodendrocytes.  In  this  study,  
Lafaille et al. reported that UNC-93B-defective neurons and oligodendrocytes were more susceptible 
to HSV-1 infection compared to wild-type control cells [43]. Susceptibility was unchanged in NSCs 
and  astrocytes.  Intriguingly,  similar  results  were  obtained  for  cells  derived  from  TLR3-defective 
neurons. These results suggest that signaling through the TLR3 pathway is necessary for efficiently 
modulating susceptibility to HSV-1 infection, specifically in neurons and astrocytes. This agrees with 
previous  work  indicating  that  TLR3-signaling  is  important  for type  I  IFN responses  and  neuronal 
resistance to HSV-1 infection [44–46]. Collectively, these studies raise the possibility that cell types in 
the  PNS  and  CNS  are  not  equally  susceptible  and  permissible  to  alphaherpesvirus  infection. 
Furthermore,  restriction  of  viral  replication  in  the  CNS  by  activation  of  TLRs  may  not  be  cell 
autonomous to CNS neurons. For example, Reinert et al. reported that TLR3 activation is responsible 
for restricting HSV-2 neuroinvasion by mediating the type I IFN response in astrocytes, thus limiting 
viral replication in CNS neurons [47]. The adaptive immune response also serves as an important line 
of  defense  against  infections  and  functions  to  modulate  viral  spread  in  the  nervous  system.  
Viral specific T-cells are generated in response to infections within peripheral ganglia. These cells 
function to control viral replication and maintain latency. This topic has been recently reviewed in  
further detail [48]. 
2. The Alphaherpesvirus Infectious Cycle 
2.1. Virion Attachment and Entry 
The directionality of spread is dependent upon the nature of the alphaherpesvirus infectious cycle 
(Figure 2). Infection is initiated by mature virions, which have a complex multilayered structure that is 
conserved among all  herpesviruses  [1]. At the core of the virion  is a linear double-stranded DNA 
genome that is packaged within a proteinaceous capsid. The capsid is surrounded by a layer of viral Viruses 2013, 5                               
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and cellular proteins known as the tegument, which is enclosed within a phospholipid bilayer studded 
with viral transmembrane proteins and is known as the virion envelope [4,49]. Infection is initiated by 
attachment of virions to heparan sulfate proteoglycans on the cell surface through the glycoproteins  
gC [50,51] and gB [52,53]. The next step of HSV-1 virion entry is dependent upon glycoprotein gD, 
which binds receptors on the surface of the plasma membrane, including Nectin-1, herpesvirus entry 
mediator (HVEM) and 3-O-sulfated heparan sulfate [54–57]. For PRV, gD is required for penetration 
of virions into cells, but not for cell-to-cell spread and neuroinvasion [58–60]. Although PRV gD binds 
Nectin-1  [61,62],  neither  Nectin-1  nor  HVEM  are  required  for  PRV  entry  and  spread  in  
fibroblasts [60]. Thus, it is likely that there are other cellular receptors for PRV. VZV does not encode 
a gD homolog and likely depends on different viral proteins for interacting with entry receptors [63]. 
VZV  gE  may  have  gD-like  functions  during  initiation  of  infection  through  binding  the  
insulin-degrading  enzyme  (IDE),  a  proposed  VZV  receptor  [64–66].  Following  virion  binding, 
glycoproteins  gB,  gH  and  gL,  mediate  fusion  of  the  virion  envelope  with  the  plasma  
membrane  [67–70]. Penetration  of  viral  particles  into the  cell  triggers  the  release  of  many  of  the 
tegument proteins into the cytoplasm [71,72]. However, a specific subset of “inner tegument” proteins 
(UL14, UL16, UL21, UL36, UL37, Us3 and ICP0) are thought to remain associated with capsids 
following  entry  [11,73].  These  capsid  tegument  complexes  are  transported  towards  the  
nucleus [71,72]. Three of these proteins (UL36, UL37 and Us3) have been shown to co-transport with 
incoming  PRV  capsids  by  live  cell  imaging  and  electron  microscopy  [10,71,72,74,75].  
Recent studies have focused on the role of the large-inner tegument protein, UL36, during viral entry.  
UL36  serves  multiple  functions  during  infection,  including  transport  of  capsids  towards  the  
nucleus [73,76], docking of capsids to the nuclear pore [74] and release of viral genomes into the 
nucleus  [77].  Upon  entering  the  nucleus,  the  linear  viral  genome  becomes  circularized.  During 
productive replication, circular genomes serve as the template for DNA synthesis. The initial theta 
replication  mechanism  switches  to  a  rolling-circle  mechanism  in  order  to  produce  long  linear 
concatemeric  genomes  that  serve  as  substrates  for  genome  encapsidation  [1,4].  Entry  of  the  viral 
genome  into  the  nucleus  also  results  in  the  initiation  of  a  highly  temporally  ordered  viral  gene 
transcription cascade that is characteristic of herpesvirus infection. Viral genes can be subdivided into 
three  classes  of  successively  expressed  transcripts  (immediate  early,  early  and  late  genes)  [1,4].  
For  PRV,  gene  transcription  is  initiated  by  expression  of  the  immediate  early  gene  IE180  (the 
homologue of HSV ICP4), a potent transcriptional activator that transinduces the expression of viral 
early genes [4,78]. Early genes primarily encode enzymes that are involved in nucleotide metabolism, 
while late genes encode structural components that are essential for genome packaging and assembly 
of new virions. Viruses 2013, 5                               
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Figure 2. The pseudorabies virus (PRV) replication cycle. Following virion attachment 
and entry, viral capsids and tegument proteins are released into the cytoplasm. Many of the 
tegument proteins previously contained within the virion are released into the cytoplasm. 
Viral capsids and a specific subset of tegument proteins are trafficked towards the nucleus, 
where the viral genome is deposited and replicated. Capsids containing newly replicated 
viral genomes are released from the nucleus into the cytoplasm, where they further mature 
by acquiring viral and host tegument proteins. Final maturation occurs by envelopment of 
viral particles into vesicles derived from the trans-Golgi network (TGN) that contain viral 
and host membrane proteins. This process, known as secondary envelopment, results in a 
mature virion that is contained within a transport vesicle. Enveloped virions are trafficked 
towards sites of egress along the cell surface. In neurons, enveloped virions are sorted into 
axons  and  transported  long  distances  along  microtubules  towards  distal  egress  sites.  
At  the  target  membrane,  the  transport  vesicle  and  plasma  membrane  fuse,  releasing  a 
mature, enveloped PRV virion from the cell. 
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2.2. Genome Replication and Nuclear Egress 
Newly replicated viral genomes are packaged into capsids in the nucleus. This process involves 
cleavage  of  the  replicated  concatemeric  DNA  into  monomeric  linear  genomes  and  subsequent 
packaging of genomes into capsids [79,80]. After packaging, PRV nucleocapsids are released from the 
nucleus by crossing the nuclear envelope and then entering the cytoplasm. The molecular details of 
this process have been subject to debate over recent years [81]. The widely accepted model suggests 
that nuclear egress is initiated when nucleocapsids bud through the inner nuclear membrane into the 
perinuclear  space  through  a  process  known  as  primary  envelopment.  This  is  followed  by  
de-envelopment  (fusion)  at  the  outer  nuclear  membrane  and  release  of  the  nucleocapsid  into  the 
cytoplasm [82,83]. Previously, this mode of nuclear egress was thought to be unique for herpesviruses. 
However, Speese et al. recently demonstrated that nuclear egress of large ribonucleoprotein particles 
(RNPs) occurs though a similar mechanism, suggesting that herpesvirus nuclear egress progresses by 
taking  advantage  of  an  existing  cellular  mechanism  [84].  Nonetheless,  efficient  nuclear  egress  of 
herpesvirus nucleocapsids is dependent upon the viral proteins UL31, UL34 and Us3 [85–90]. Recent 
work  has  shown  that  additional  viral  tegument  and  membrane  glycoproteins  are  associated  with 
primary enveloped virions [91–94]; the putative roles of these proteins during nuclear egress remain 
poorly understood. 
2.3. Virion Assembly, Secondary Envelopment and Cellular Egress  
Following nuclear egress, virions undergo assembly and maturation in the cytoplasm, where they 
acquire tegument proteins and bud into vesicles that give rise to the final envelope [49]. Membrane 
acquisition of tegument-coated capsids occurs through a process known as secondary envelopment. 
This process produces enveloped virions that are contained within a transport vesicle. The cellular 
membranes used for secondary envelopment of PRV and HSV-1 have been shown to contain markers 
for the trans-Golgi  network (TGN) [95–98]. However,  it  is also  important to note that productive 
herpesvirus  infection results  in a dramatic rearrangement of  membranous organelles,  including the 
Golgi apparatus, TGN and endosomes, such that their subcellular localizations and boundaries become 
less  well  defined  compared  to  uninfected  cells  [97,99].  Thus,  while  the  exact  cellular  origin  of 
membranes used for secondary envelopment remains unknown, these membranes contain a subset of 
viral and cellular proteins that facilitate virion assembly and egress. 
For viral particles that are targeted for egress in axons, a lively debate has arisen regarding the 
assembly state of these particles prior to axonal sorting [11,100,101]. The “married model” holds that 
virion assembly and secondary envelopment occur in the cell body prior to axonal sorting and transport 
towards sites of egress at distal sites  [83,102–118]. In contrast, under the “separate model” naked 
capsids (nucleocapsids that associate with a subset of tegument proteins, but not membranes) and 
secondary envelopment membranes undergo axonal sorting and transport separately. Final assembly of 
these  components  occurs  at  or  near  sites  of  egress  [103,119–127].  Kratchmarov  et  al.  recently 
presented a comprehensive review of the published evidence that supports each of these models [100]. 
An important conclusion is that overwhelming amounts of data support the married model during PRV Viruses 2013, 5                               
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infection. Further work is necessary to assess whether axonal sorting and transport of HSV-1 follows 
the married or separate models or, potentially, a combination of both [103]. 
Virion egress occurs by fusion between the transport vesicle membrane and the plasma membrane 
to  releases  virions  into  the  extracellular  environment.  The  molecular  mechanism  underlying  these 
fusion events is unknown, but is likely dependent upon soluble N-ethylmaleimide attachment protein 
receptor (SNARE) proteins that mediate exocytosis of cellular vesicles [128–130]. Previous studies 
have demonstrated that HSV-1 and PRV particles are associated and co-transport with proteins that are 
involved in axonal secretory and exocytic pathways [105,120]. Furthermore, we recently found that the 
vesicle and target SNAREs (v-SNAREs and t-SNAREs), VAMP2, SNAP-25, VTI1B and Syntaxin-6 
are incorporated with membrane microdomains that contain the PRV membrane protein Us9  [131].  
As discussed below, since PRV Us9 is required for anterograde spread of  infection, these cellular 
fusion  proteins  represent  excellent  candidates  for  mediating  targeted  virion  egress  in  axons  
and dendrites.  
3. Utilization of the Host Cytoskeleton for Directional Spread of Infection in Neurons 
3.1. Viral Particle Movement Requires Active Transport 
Many viruses, including PRV and HSV, rely on interactions with the host cytoskeleton for effective 
spread and transmission. Diffusion is an inefficient means for long-distance directional movement of 
viral particles within the cytoplasm. An HSV capsid would take over 200 years to move 1 cm by 
diffusion alone [132]. This timescale is far too extended for efficient movement of viral particles in 
mammalian cells, let alone highly elongated cells, such as neurons that extend neurites millimeters or 
even meters away from their cell bodies. Thus, active transport via established cellular mechanisms is 
required for efficient viral infection and spread. 
3.2. The Actin and Microtubule Cytoskeletons 
Both  the  actin  and  microtubule  cytoskeleton  have  well-established  roles  during  herpesvirus 
infection  [21,133,134].  Actin  filaments  (F-actin)  play  an  essential  role  in  short-distance  cargo 
movement  [135–138].  Filaments  are  composed  of  G-actin  monomer  subunits  that  form  two 
protofilaments  that  wrap  around  each  other  [139].  This  arrangement  confers  an  intrinsic  polarity 
consisting of “plus” (or “barbed”) and “minus” (or “pointed”) ends. Actin filaments range between 5 to 
9 nm in diameter and often form three-dimensional networks within the cell, but are concentrated at 
the cell cortex [140]. Directed transport of cellular cargoes is mediated by the myosin superfamily of 
motor proteins [141]. Several members of this large superfamily of motors have been shown to be 
involved in targeting proteins to axons [142,143].  
In  contrast  to  the  actin  cytoskeleton,  microtubules  are  required  for  facilitating  long  distance 
transport  of  cargo.  Microtubules  are  stiff  cylinders  composed  of  alpha-tubulin  and  beta-tubulin 
heterodimeric subunits that assemble through head-to-tail association to form protofilaments [144]. 
Typically, 13 of these protofilaments join to form a hollow microtubule that has an outer diameter of 
25 nm. Because of their composition, microtubule filaments possess an inherent structural polarity. 
Microtubules have a highly dynamic “plus” end that is often oriented towards the cell periphery, as Viruses 2013, 5                               
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well  as  a  relative  stable  “minus”  end  that  is  oriented  towards  the  microtubule  organizing  center 
(MTOC) [145–147]. In neurons, the arrangement of microtubules is highly specialized. Axons contain 
microtubules  that  are  oriented  almost  exclusively  with  plus-ends  facing  the  axon  terminus,  while 
dendrites contain microtubules of mixed polarity [143,148]. This mode of organization is required for 
maintaining the identities of these distinct neuronal compartments. Two classes of molecular motor 
proteins  mediate  microtubule-dependent  directional  transport  of  cargoes.  Dynein  motors  facilitate 
retrograde  transport  (towards  the  microtubule  minus  ends),  while  kinesin  family  motors  facilitate 
anterograde transport  (towards the  microtubule  plus  ends)  [149].  The  kinesin  family  of  motors  is 
substantially more diverse; mammalian genomes can encode up to 45 different kinesin motors that are 
classified into 14 different subfamilies [143,150].  
The  actin  and  microtubule  cytoskeletons  often  function  cooperatively  to  maintain  and  facilitate 
proper  cellular  polarity  and  dynamics  [151,152].  For  example,  the  proximal  axon  is  enriched  in 
filamentous  actin  [153],  as  well  as  microtubule  ends  that  are  decorated  with  the  microtubule  
end-binding (EB) proteins, EB1 and EB3 [154,155]. These structural components are anchored by the 
large scaffolding protein, ankyrin G, a key organizer of the axon initial segment [156]. Combined, 
these  structural  properties  of  the  axon  initial  segment  allow  it to  function  as  a  selective  filter  for 
regulating transport of cellular components into the axonal compartment [153]. 
3.3. Retrograde Transport During Viral Entry 
To  gain  access  to  the  cytoplasm,  incoming  viral  particles  must  get  past  a  layer  of  cortical  
actin  [157].  While  virion  binding  to  cell  surface  receptors  triggers  rearrangement  of  the  actin 
cytoskeleton [158,159], the importance of this event is currently unknown. Pretreatment of cells with 
the actin depolymerizing agent, cytochalasin D, does not affect the dynamics of viral entry  [157].  
In  contrast,  pretreatment  of  cells  with  the  microtubule  depolymerizing  agents,  nocodazole  or 
colchicine, results in disruption of retrograde capsid transport towards the nucleus, demonstrating that 
the microtubule cytoskeleton is required for entry  [22,157,160]. Live cell imaging of fluorescently 
labeled PRV and HSV-1 capsids in cultured neurons has shown that retrograde transport is a robust 
process that occurs at a rate of approximately 1 μm/s [22,105,109,160–162]. This rate is consistent 
with fast axonal transport with the retrograde motor dynein [163]. Additionally, retrograde transport of 
capsids is salutatory and bidirectional, suggesting that kinesin motors may also be involved [105,162]. 
Both kinesin-1 and kinesin-2 have been shown to co-purify with partially tegumented capsids that 
were generated from extracellular virions and incubated in cytosolic extracts [73]. 
A small subset of viral capsid and tegument proteins have been implicated in recruiting motors that 
facilitate  retrograde  transport,  including  UL36,  UL37  and  VP26  (UL35)  [73,74,76,164–167].  
UL36 has emerged as the  most likely candidate for direct motor recruitment to incoming virions. 
Expression  of  mutant  UL36  proteins  or  injection  of  anti-UL36  antibodies  results  in  a  
dramatic  disruption  of  capsid  delivery  to  the  nucleus  and,  consequently,  initiation  of  
infection [74,76,166,168,169]. In contrast, deletion or mutation of UL37 or VP26 does not appear to 
have the same effect [165,170–172]. Viruses 2013, 5                               
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3.4. Anterograde Viral Transport and Axonal Sorting 
In  addition  to  its  role  during  entry,  UL36  is  required  for  transport  to  the  site  of  secondary 
envelopment and egress [173,174]. In the absence of UL36, PRV capsids are not transported along 
microtubules  and  do  not  undergo  secondary  envelopment.  PRV  deleted  for  UL37  is  defective  for 
secondary envelopment and displays reduced capsid transport (UL36 still binds capsids in UL37 null 
PRV) [76]. These observations suggest that UL36 and UL37 are key components of a motor protein 
recruitment complex that transports tegumented (or partially tegumented) capsids towards assembly 
sites. Presumably, these transport events depend primarily upon interactions with kinesin motors (as 
opposed to dynein). However, since the tegument compositions of newly produced nucleocapsids and 
incoming capsids appear to be similar (capsid proteins bound to UL36, UL37 and Us3), this leads to an 
apparent  problem.  How  are  capsids  differentially  targeted  to  the  nucleus  for  entry  or  to  sites  of 
cytoplasmic envelopment for egress? Since UL36 has been shown to interact with motor proteins of 
opposite polarity (G.A. Smith, personal communication), it likely has the capacity to transport viral 
particles in both the anterograde and retrograde directions. Posttranslational modifications or binding 
of accessory viral tegument proteins are predicted to act as the “switch” between dynein and kinesin 
driven transport [175–180]. 
Following secondary envelopment in the cytoplasm, viral particles are further transported towards 
sites of egress along the cell periphery. This process is also sensitive to microtubule depolymerizing 
agents  and,  therefore,  requires  kinesin  motors  [125].  The  specific  viral  and  cellular  proteins  that 
mediate this process have not been previously identified. 
In  non-neuronal  cells,  UL36  and  Us11  have  been  proposed  as  candidate  viral  
proteins  for  recruitment  of  kinesin  motors  during  anterograde  transport  of  enveloped  viral  
particles [167,181–184]. Both proteins have been shown biochemically to interact with kinesin motor 
subunits.  However,  since  UL36  and  Us11  are  tegument  proteins,  they  are  unlikely  to  partake  in 
protein-protein interactions on the cytoplasmic surface of enveloped particles. One possibility is that a 
subset of tegument proteins, including UL36, may be membrane-associated and available on the outer 
surface of enveloped particles [185–188]. A second model holds that virions are partially enveloped, 
thus rendering the tegument exposed to cytosolic proteins [167]. Moreover, the potential involvement 
of  Us11  in  anterograde  transport  of  enveloped  virions  poses  addition  caveats.  First,  Us11  is  
non-essential for viral replication. Second, Us11 is not conserved in all alphaherpesviruses, including 
PRV [182,183]. Thus, further work is needed to identify the viral and  host proteins that facilitate 
anterograde transport of enveloped virions. 
During neuronal infection, anterograde spread is dependent upon axonal sorting and long distance 
transport  of  viral  particles.  Anterograde-directed  movement  of  viral  particles  is  necessary  for  
re-infection of  innervated tissues  following reactivation from latency and, consequently, successful 
spread between hosts. Three viral membrane proteins (gE, gI and Us9) are required for anterograde 
directed spread through neural circuits in vivo [37,189–196]. In vitro, the phenotype of individual gE, 
gI or Us9 null mutants are more varied (Figure 3). PRV gE and gI null mutants are able to undergo 
anterograde spread, but with a reduced capacity compared to wild-type [197]. Us9 null mutants display 
the most severe phenotype and are completely defective for anterograde transneuronal spread [108]. Viruses 2013, 5                               
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All three of these proteins are required for efficient targeting of virion structural components into 
axons [108,111,124]. gE/gI are both type I membrane proteins that form a heterodimer within the 
endoplasmic reticulum (ER) [195]. After leaving the ER, gE/gI are localized primarily to the Golgi 
apparatus, cytoplasmic vesicles and the plasma membrane [198,199]. By biotin labeling of cell surface 
proteins or using specific antibodies, our lab demonstrated that gE/gI undergo constitutive endocytosis 
from the plasma membrane and accumulate in large cytoplasmic vesicles. In porcine kidney epithelial 
cells (PK15), endocytosis of the gE/gI complex occurs early after infection, but stops completely after 
6  hours  post  infection  (HPI)  [198].  Endocytosis  of  gE/gI  is  dependent  upon  the  123  amino  acid 
cytoplasmic  tail  domain  of  gE  (the  full  length  protein  contains  577  amino  acids),  especially  a 
membrane proximal tyrosine-based internalization motif (at amino acids 478–481) [200,201]. Both 
HSV-1 and VZV gE also contain similar tyrosine-based motifs within their cytoplasmic domains that 
are important for endocytosis [200]. For PRV, this domain is not required for transneuronal spread of 
infection in vivo [199,201]. However, deletion of gE’s cytoplasmic domain or the full length protein 
results  in  a  small  plaque  phenotype  in  non-neuronal  cell  types,  suggesting  that  it  is  required  for  
cell-to-cell spread in a variety of cell types [199,201]. In contrast, Us9 null mutants form plaques that 
are comparable in size to those formed by wild-type PRV [190]. Overall, these results imply that gE/gI 
and Us9 have distinct functions for mediating anterograde transneuronal spread. 
Us9 is a small (106 amino acid) type II tail-anchored membrane protein that is expressed with late 
kinetics  and  is  enriched  within  detergent  resistant  membrane  microdomains,  known  as  lipid  
rafts [202,203]. In the absence of Us9, viral particles are assembled in the cell body, but are unable to 
sort into axons (Figure 3) [102,108]. Moreover, the Us9 null phenotype is neuron-specific. A long held 
hypothesis had been that Us9 functions by interacting directly or indirectly with a kinesin motor or 
cellular  adaptor  complex  that  facilitates  axonal  sorting  and  transport  [124,204].  Despite  numerous 
attempts to identify viral and host proteins that interact with Us9, the molecular mechanism underlying 
its function remained elusive for many years [108,124,203]. We recently reported that Us9 interacts 
with  KIF1A,  a  member  of  the  kinesin-3  family  of  microtubule-dependent  molecular  motors.  
Our results imply that KIF1A is also required for axonal sorting and long-distance transport of viral 
particles towards egress sites in axons. Multiple known properties of KIF1A function are consistent 
with  its  role  in  mediating  axonal  sorting  and  transport  of  viral  particles.  First,  KIF1A  is  highly 
expressed in neuronal tissues and is enriched in axons [205,206], thus making it an excellent candidate 
for  facilitating  anterograde  spread  of  neurotropic  alphaherpesviruses.  Second,  KIF1A  has  a  
well-established functional roll in axonal sorting and transport of cargoes, such as synaptic vesicle 
precursors and dense core vesicles [207]. Several laboratories have reported that loss of KIF1A leads 
to a reduced number of synaptic vesicle precursors in axons and accumulation of these organelles in 
cell bodies [208–210]. The Us9 null phenotype is strikingly similar [108,203]. Finally, KIF1A is a 
relatively  fast  kinesin  motor,  with  average  velocities  of  1.2-2.5  μm/s,  depending  on  the  model  
system [211]. The measured average velocity of anterograde-directed PRV capsids in axons is within 
this range (1.97 μm/s) [212]. Similarly, the velocity of anterograde transport of VZV particles has been 
estimated at 1.5 μm/s [213]. However, we cannot exclude the possibility that other kinesin motors are 
involved  in axonal transport of viral particles after axonal  sorting. If so, recruitment of additional 
motor proteins is likely independent of Us9.  Viruses 2013, 5                               
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Figure 3. PRV Us9 and gE/gI mediate anterograde spread of infection in neurons. PRV 
Us9 is essential for anterograde trans-neuronal spread in vivo and in vitro. In the absence of 
Us9, viral particles are assembled  in the cell  body, but are not sorted into axons. This 
neuron-specific phenotype suggests that Us9 functions  by recruiting a  molecular  motor 
protein, either directly or indirectly, that facilitates axonal sorting of viral particles into 
axons. In contrast, gE/gI null mutants are defective for anterograde trans-neuronal spread 
in vivo, but are able to spread with reduced capacity in vitro. gE/gI null mutants display a 
small plaque phenotype in non-neuronal cell types. 
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Our  results  also  imply  that  at  least  one  additional  kinesin  motor  is  required  for  transport  of 
enveloped  viral particles  in neuron cell  bodies and non-neuronal cells. The evidence for this  is as 
follows: (1) Retrograde transneuronal spread is unaltered during infection with PRV strains that are 
Us9 null [190]. (2) The Us9 null phenotype is neuron specific. Cell types that do not express KIF1A, 
such as epithelial cells, are susceptible and permissive to PRV infection and are capable of facilitating  
cell-to-cell spread of infection [124]. Both of these observations necessitate active transport of viral 
components towards sites of egress at the plasma membrane of cell bodies. (3) Previous studies have 
implicated  other  motor  proteins  in  intracellular  transport  of  viral  structural  components  in  
non-neuronal cells [73,101,167,214]. Unlike KIF1A, which is expressed exclusively in neurons, these 
motors are expressed in a variety of cell types [143,215]. While the viral and host proteins that mediate 
these transport events are still unknown, kinesin-1 represents an excellent candidate, both because of 
its well-characterized  function  in transporting a  broad range of cellular cargoes and  its ubiquitous 
expression in virtually all mammalian cell types [215].  
Viral  membrane-associated  proteins  represent  the  most  likely  candidates  for  recruiting  motor 
protein subunits to enveloped virions. In this case, deletion of these viral membrane proteins would 
produce a phenotype in which virions are assembled, but remain stationary and accumulate within cell 
bodies of non-neuronal cells (following transfection of mutant viral DNA). However, it has also been 
proposed that non-membrane associated viral proteins, such as UL36, may also act as receptors for 
kinesin  motors following  secondary envelopment  [11,167]. This  model  is dependent upon UL36’s 
putative  localization  on  the  cytoplasmic  surface  of  the  transport  vesicle  surrounding  intracellular 
enveloped viral particles, in addition to its well-characterized localization within the tegument layer of 
virions.  Finally,  it  is  also  possible  that  cellular  proteins  mediate  recruitment of  kinesin-1  or other 
motors (besides KIF1A) onto enveloped viral particles. 
3.5. Reorganization of the Cytoskeleton and Alteration of Organelle Dynamics During Infection 
Alphaherpesvirus infections induce alterations of actin filaments, microtubules and other cellular 
organelles  in  a  variety  of  cell  types  [21,133,134].  For  example,  the  viral  kinase,  Us3,  promotes 
disassembly of actin stress fibers and outgrowth of cellular protrusions that are proposed to enhance 
cell-to-cell spread and viral egress [216]. Consistent with this, Roberts and Baines demonstrated that 
the actin-dependent  motor myosin Va  has a role  in targeting  viral  membrane glycoproteins to the 
plasma membrane [214]. Alphaherpesvirus proteins that affect the microtubule cytoskeleton include 
HSV-1 ICP0, a ring finger E3 ubiquitin ligase that plays a key role in establishing infection. ICP0 is 
multifunction  and  has  been  shown  to  bundle  and  dismantle  microtubules  in  transfected or  HSV-1 
infected Vero cells [217].  
In neurons, altered or aberrant neuronal firing activity leads to reorganization of key cytoskeletal 
components and changes in organelle dynamics. Two prominent examples are modification of the size 
and  localization  of  the  axon  initial  segment,  as  well  as  alteration  of  mitochondrial  dynamics  in 
response  to  increased  action  potential  firing  [218–222]. These  changes  have  been  implicated  in  a 
variety  of  neurological  diseases  and  disorders  [223,224].  Our  lab  previously  reported  that  action 
potential firing rates dramatically increase beginning at 8-10 hours post PRV infection in cultured rat 
superior cervical ganglion (SCG) neurons [225]. Consequently, this results in elevated intracellular Viruses 2013, 5                               
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Ca
2+ and alters mitochondrial dynamics through a mechanism involving the Ca
2+-sensitive protein, 
Miro,  a  cellular  protein  that  regulates  mitochondrial  motor  activity  [218,220,226].  Our  findings 
suggest that disruption of  mitochondrial  motility is  important for efficient spread of  infection. We 
hypothesized that this could be due to removal of kinesin-1 from mitochondria for efficient transport of 
viral particles and, consequently, spread within and between hosts [226]. This hypothesis was based on 
two observations: (1) kinesin-1 recruitment to mitochondria through Miro is disrupted during infection 
and (2) PRV overexpressing Ca
2+-insensitive Miro proteins (PRV Miro1ΔEF) is deficient for spread in 
both PK15 cells and SCG neurons. However, our findings do not exclude the possibility that disruption 
of mitochondrial motility may be important for other aspects of viral infection and spread (besides 
viral particle transport). One possibility is that disruption of mitochondrial dynamics through Miro’s  
Ca
2+-sensitive  function  may  be  important  for  maintaining  cell  viability  by  blocking  apoptosis.  
In neurons, elevated intracellular Ca
2+ results in excitotoxic stress that leads to cell death [227]. It is 
remarkable that neurons cultured in vitro are able to survive for several days post infection [225] and 
do  not  die  of  excitotoxic  Ca
2+  overload.  Alternatively,  disruption  mitochondrial  dynamics  during 
infection may interfere with cellular antiviral signaling cascades that are mediated by mitochondrial 
membrane proteins. For example, activation of retinoic acid-inducible gene I-like receptors (RLRs) 
promotes  elongation  of  the  mitochondrial  network.  During  infection,  this  is  important  for  signal 
transduction through the mitochondrial antiviral signal (MAVS) protein, which triggers the production 
of type I interferons and proinflammatory cytokines. Castanier et al. previously demonstrated that a 
human  cytomegalovirus  (HMCV)  antiapoptotic  protein  that  promotes  mitochondrial  fragmentation 
inhibits  signaling  downstream  from  MAVS  [228].  This  may  be  a  novel  HCMV  immune  
modulation strategy. 
Thus,  disruption  of  cytoskeletal  and  organelle  dynamics  during  infection  may  be  necessary  
for mediating efficient viral spread. Further work is needed to identify additional intracellular changes 
that occur during infection and determine their potential role in promoting viral replication, growth  
and spread. 
4. Concluding Remarks 
Directional  movement  of  alphaherpesvirus  infection  in  the  nervous  system  is  essential  for 
replication and spread within and between hosts. Efficient spread of infection in and out of the nervous 
system is dependent upon long distance transport of viral particles in axons and dendrites. Transport of 
viral particles, like other cargoes, requires the microtubule-dependent molecular motors. Retrograde 
transport is dependent on interactions between incoming capsids and tegument proteins with dynein 
motors. For anterograde spread of infection, plus-end directed kinesin motors facilitate movement of 
viral particles towards distal sites of egress. The protein composition of  viral particles determines 
which motors are recruited and activated, thus determining the destination of these particles within 
infected cells. Additional work is needed to understand how viral complexes utilize host proteins for 
efficient  long  distance  transport  within  their  hosts.  In  addition,  future  studies  will  explore  the 
significance  of  alterations  to  cellular  organization,  dynamics  and  homeostasis  that  occur  as  a 
consequence  of  infection.  These  types  of  studies  are  necessary  for  understanding  the  nature  of 
alphaherpesvirus spread and pathogenesis in the nervous system. Viruses 2013, 5                               
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